Max Homa shares his journey with seborrheic dermatitis to encourage others to take control of their symptomsZORYVE® (roflumilast) foam 0.3% is a ...

Commonly known as atopic dermatitis, eczema is "the itch that rashes," says Dr. Shi, meaning that an itching sensation often occurs first followed by a visible rash that develops after scratching.

Hot off its first approval this summer in psoriasis, Arcutis Biotherapeutics’ roflumilast foam 0.3%, approved in cream form under the brand name Zoryve, is out to prove it’s no one-trick pony in itch.

Medically reviewed by Brendan Camp, MD Seborrheic dermatitis and scalp psoriasis commonly cause dandruff, which may lead to ...

Max Homa opens up about joining the Free to Be Me campaign, sharing his personal health journey and encouraging others to seek proper care.

A recent Phase 3 clinical trial demonstrated that a steroid-free topical foam, roflumilast (Zoryve), significantly improved the signs and symptoms of psoriasis on both the scalp and body. The foam ...

When a person presents with features of both psoriasis and seborrheic dermatitis (SD), a healthcare professional may diagnose sebopsoriasis. This is a chronic skin condition that has symptoms that ...

Executives from Arcutis Biotherapeutics (NASDAQ:ARQT) outlined their commercial priorities for the ZORYVE franchise, ...